IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Identification of Novel BCL- 2-Specific Inhibitors from Murva - A Promising Ayurvedic Anticancer Agent (In Vitro & In Vivo Studies)

Author: RAJU ASIRVATHAM, APARNA ANN MATHEW, PRIYA PN, MARTIN C, DINU GEORGE, DAISY PA
Abstract: This study focused on identification of antiproliferative mechanism of Murva by in silico methods and compared the in vivo anticancer activity of methanol extracts of Marsdenia tenacissima (MEMT) and Sansevieria roxburghiana (MESR), are known to be Murva. PASS online study was carried out with Dresgenin from M.tenacissima and Lupeol from S.roxburghiana to know the possible biological activities and were taken as ligands for the target BCL-2 protein. Tryphan blue dye exclusion assay was done with different concentration of MEMT and MESR. In in vivo, 90 mice were organized in to 9 groups with ten mice in each. All animals except group I, intraperitoneal inoculated with DLA cell lines. Group I-normal control received distilled water, Group II cancer control received distilled water, Group III -received 20mg/kg of standard 5- Fluorouracil, i.p, Group IV - 100mg/kg of Venetoclax, p.o, Group V &VI treated with 100 and 200mg/kg of MEMT, Group VII &VIII treated with 50 and 100mg/kg of MESR and IX received combination of MEMT & MESR for 14 days. On 15th day haematological and tissue antioxidant level were measured. Insilico study results revealed that ligand has antineoplastic and Caspase 3 stimulant activity, binding scores of -9.1 and -9.2 (Kcal/mol) with BCL-2. In vitro cytotoxicity result showed MEMT (56%), MESR (68%) and the combination (92%) of cell death. In in vivo study, most significant (p<0.001) effect with combination on altered haematological and antioxidant level. The pharmacological effect was due the binding of Dresgenin and Lupeol binds with BCL- 2 protein.
Keyword: Murva, Marsdenia tenacissima, Sansevieria roxburghiana, insilico studies, anticancer, molecular docking, DLA, Tryphan blue
DOI: https://doi.org/10.31838/ijpr/2021.13.02.228
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free